These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33752475)

  • 61. Long non-coding RNA HNF1A-AS1 promotes hepatocellular carcinoma cell proliferation by repressing NKD1 and P21 expression.
    Wang C; Mou L; Chai HX; Wang F; Yin YZ; Zhang XY
    Biomed Pharmacother; 2017 May; 89():926-932. PubMed ID: 28292020
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human iPSCs-Derived Endothelial Cells with Mutation in
    Kachamakova-Trojanowska N; Stepniewski J; Dulak J
    Cells; 2019 Nov; 8(11):. PubMed ID: 31739614
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of circulating microRNAs in HNF1A-MODY carriers.
    Bonner C; Nyhan KC; Bacon S; Kyithar MP; Schmid J; Concannon CG; Bray IM; Stallings RL; Prehn JH; Byrne MM
    Diabetologia; 2013 Aug; 56(8):1743-51. PubMed ID: 23674172
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
    Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
    BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation.
    Willson JS; Godwin TD; Wiggins GA; Guilford PJ; McCall JL
    J Hepatol; 2013 Oct; 59(4):904-7. PubMed ID: 23707370
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature.
    Fu J; Wang T; Zhai X; Xiao X
    Endocrine; 2020 Mar; 67(3):544-551. PubMed ID: 31754975
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [HNF1A-AS1 inhibits proliferation, migration and invasion of IL-6-induced hemangioma endothelial cells by targeting miR-363-3p].
    Xu W; Tao S; Zhu X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Nov; 38(11):1091-1096. PubMed ID: 34729750
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Functional characterization of p.Pro409His variant in HNF1A, a hypomorphic mutation involved in pancreatic β-cell dysfunction.
    Nocera D; Menniti M; Belviso S; Bond HM; Lanzillotta D; Spoleti CB; Guagliardi MR; Malatesta P; Trapasso F; Irace C; Perrotti N; Iuliano R
    Acta Diabetol; 2019 Aug; 56(8):883-888. PubMed ID: 30963309
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer.
    Lin T; Qiu Y; Peng W; Peng L
    Biomed Res Int; 2020; 2020():2148253. PubMed ID: 33145341
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tubular proteinuria in patients with HNF1α mutations: HNF1α drives endocytosis in the proximal tubule.
    Terryn S; Tanaka K; Lengelé JP; Olinger E; Dubois-Laforgue D; Garbay S; Kozyraki R; Van Der Smissen P; Christensen EI; Courtoy PJ; Bellanné-Chantelot C; Timsit J; Pontoglio M; Devuyst O
    Kidney Int; 2016 May; 89(5):1075-1089. PubMed ID: 27083284
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Meglitinide analogues in adolescent patients with HNF1A-MODY (MODY 3).
    Becker M; Galler A; Raile K
    Pediatrics; 2014 Mar; 133(3):e775-9. PubMed ID: 24567025
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.
    Szopa M; Klupa T; Kapusta M; Matejko B; Ucieklak D; Glodzik W; Zapala B; Sani CM; Hohendorff J; Malecki MT; Skupien J
    Endocrine; 2019 Apr; 64(1):75-81. PubMed ID: 30778899
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Circulating CD36 is reduced in HNF1A-MODY carriers.
    Bacon S; Kyithar MP; Schmid J; Costa Pozza A; Handberg A; Byrne MM
    PLoS One; 2013; 8(9):e74577. PubMed ID: 24069322
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long non-coding RNA HNF1A-AS1 functioned as an oncogene and autophagy promoter in hepatocellular carcinoma through sponging hsa-miR-30b-5p.
    Liu Z; Wei X; Zhang A; Li C; Bai J; Dong J
    Biochem Biophys Res Commun; 2016 May; 473(4):1268-1275. PubMed ID: 27084450
    [TBL] [Abstract][Full Text] [Related]  

  • 75. High Incidence of Heterozygous ABCC8 and HNF1A Mutations in Czech Patients With Congenital Hyperinsulinism.
    Rozenkova K; Malikova J; Nessa A; Dusatkova L; Bjørkhaug L; Obermannova B; Dusatkova P; Kytnarova J; Aukrust I; Najmi LA; Rypackova B; Sumnik Z; Lebl J; Njølstad PR; Hussain K; Pruhova S
    J Clin Endocrinol Metab; 2015 Dec; 100(12):E1540-9. PubMed ID: 26431509
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Maturity-onset diabetes of the young and hepatic adenomatosis - characterisation of a new mutation.
    Iwen KA; Klein J; Hubold C; Lehnert H; Weitzel JM
    Exp Clin Endocrinol Diabetes; 2013 Jun; 121(6):368-71. PubMed ID: 23616187
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome.
    Zoldoš V; Horvat T; Novokmet M; Cuenin C; Mužinić A; Pučić M; Huffman JE; Gornik O; Polašek O; Campbell H; Hayward C; Wright AF; Rudan I; Owen K; McCarthy MI; Herceg Z; Lauc G
    Epigenetics; 2012 Feb; 7(2):164-72. PubMed ID: 22395466
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Integrative Analysis of Siglec-15 mRNA in Human Cancers Based on Data Mining.
    Li QT; Huang ZZ; Chen YB; Yao HY; Ke ZH; He XX; Qiu MJ; Wang MM; Xiong ZF; Yang SL
    J Cancer; 2020; 11(9):2453-2464. PubMed ID: 32201516
    [No Abstract]   [Full Text] [Related]  

  • 79. Long non-coding RNA HNF1A-AS1 promotes cell viability and migration in human bladder cancer.
    Feng Z; Wang B
    Oncol Lett; 2018 Apr; 15(4):4535-4540. PubMed ID: 29541223
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
    Xu HH; Gan J; Xu DP; Li L; Yan WH
    Front Immunol; 2021; 12():614773. PubMed ID: 34276642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.